Russell Goetze
Director, Analytical Development Regeneron Pharmaceuticals
Russell G. is a Passionate technical leader developing cellular immunotherapies to treat cancer and an Effective communicator with a proven track record of delivering analytical CMC packages. He brings extensive experience in Process and Analytical Science, CMC, and Cell Therapy through leadership roles at Regeneron and 2seventy bio. His background includes advancing CAR T and TCR T programs and leading Method Development, Qualification, and Analytical Operations. Russell holds a Doctor of Philosophy Ph.D. Molecular and Systems Pharmacology from Emory University and a Bachelor of Science Biochemistry and Molecular Biology from The University of Georgia.
Seminars
Wednesday 16th September 2026
Advancing Cytotoxicity Assays to Strengthen Early CAR-T Development Decisions
3:30 pm
- Leveraging real-time monitoring to enable tumor rechallenge experiments and deeper insight into CAR-T cytotoxic durability and functional exhaustion
- Identifying clinical correlates for preclinical assay results to ensure streamlined Phase I clinical testing
- Applying dynamic assay data to better characterize the cytotoxic profile of final CAR-T products and support confident preclinical-to–Phase I translation
